MLND - Millendo Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Millendo Therapeutics's activity chart (see below) currently has 11 price targets and 10 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 271.25 days.

Most recent stock forecast was given by from LADENBURG on 06-Jan-2021. First documented stock forecast 16-Jul-2019.

Best performing analysts who are covering MLND - Millendo Therapeutics:

Jay Olson Joel Beatty Matthew Kaplan Laura Chico

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Apr-2020

$5

5 years 8 months 7 days ago
(06-Jan-2021)

2/2 (100%)

$-21.85 (-81.38%)

592

Buy Since 11-Mar-2020

$25

6 years 5 months 7 days ago
(06-Apr-2020)

1/1 (100%)

$-73.7 (-74.67%)

26

Buy Since 07-Feb-2020

$20

$16.71 (507.90%)

$23

6 years 5 months 20 days ago
(24-Mar-2020)

2/2 (100%)

$-76.15 (-79.20%)

215

Buy Since 16-Jul-2019

$25

$21.71 (659.88%)

7 years 1 months ago
(13-Aug-2019)

2/2 (100%)

$-81.5 (-76.53%)

252

Show more analysts

Please expand the browser size to see the chart

What is MLND (Millendo Therapeutics) average time for price targets to be met?

On average it took 271 days for the stock forecasts to be reached, with an average price target met ratio of 100%.

Which analyst most recently updated their price target on MLND (Millendo Therapeutics)?

Which analyst has the most public recommendations on MLND (Millendo Therapeutics)?

has 0 price targets and 0 ratings on MLND

Which analyst is the currently most bullish on MLND (Millendo Therapeutics)?

Jay Olson with the highest potential upside of $21.71

Which analyst is the currently most reserved on MLND (Millendo Therapeutics)?

Laura Chico with the lowest potential downside of -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?